跳轉至內容
Merck
  • "Single-pot" approach towards the preparation of alkyl and polyfluoroalkyl organo-silica monolithic capillaries for reversed-phase liquid chromatography.

"Single-pot" approach towards the preparation of alkyl and polyfluoroalkyl organo-silica monolithic capillaries for reversed-phase liquid chromatography.

Journal of separation science (2018-08-01)
Lucas Narciso Meirelles, Thales Silva Campos, Zulema Rodriguez, Rebecca Hernandez, Frantisek Svec, Zuzana Zajickova
摘要

Organo-silica monolithic capillary columns were prepared using thermally initiated polymerization of mixtures containing 3-(methacryloyloxy)propyltrimethoxysilane as the silicon-containing monomer, an aqueous acid catalyst, ethylene dimethacrylate as the cross-linker, a functional monomer selected from the group comprising octadecyl methacrylate, trifluoroethyl methacrylate, pentafluoropropyl methacrylate, and heptadecafluorodecyl methacrylate, toluene as the porogen, and 2,2'-azobisisobutyronitrile as the initiator. The permeability of the monoliths was controlled by varying the composition of the polymerization mixture. Chromatographic properties of resulting monolithic 100 μm i.d. capillaries were evaluated utilizing four sets of probe compounds under isocratic elution conditions in the reversed-phase mode. Baseline separation of alkylbenzenes and the best steric selectivity were achieved using the octadecyl methacrylate monolithic column verifying that its surface was the most hydrophobic. In contrast, separation of a mixture containing polar compounds was observed using columns prepared in the absence of the functional monomer due to the presence of residual surface silanols at the pore surface. Polyfluoroalkyl stationary phases, especially those with a high number of fluorine atoms, exhibited the highest selectivity towards fluorine-containing analytes.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
乙二醇二甲基丙烯酸酯, 98%, contains 90-110 ppm monomethyl ether hydroquinone as inhibitor
Sigma-Aldrich
2,2,3,3,3-五氟丙基甲基丙烯酸盐, 97%, contains 100 ppm 4-tert-butylcatechol as inhibitor